All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
TLGT / Teligent Inc
|
|
|
|
|
|
|
|
OEF / iShares Trust - iShares S&P 100 ETF Put
|
|
|
|
|
|
|
|
ZCOR / Zyla Life Sciences
|
|
|
|
|
|
|
|
GBT / Global Blood Therapeutics Inc.
|
|
|
|
|
|
|
|
FBIO / Fortress Biotech, Inc.
|
|
|
|
|
|
|
|
AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
ONSIZ / Oncobiologics, Inc. Series B Warrant Expiring 5/18
|
|
|
|
|
|
|
|
71426VAK4 / Pernix Therapeutics Holdings, Inc. Convertible Debt 4.25%
|
|
|
|
|
|
|
|
/ Immunomedics, Inc.
|
|
|
|
|
|
|
|
ONTY / Oncothyreon, Inc.
|
|
|
|
|
|
|
|
AKBA / Akebia Therapeutics, Inc.
|
|
|
|
|
|
|
|
/ Immunomedics, Inc. Call
|
|
|
|
|
|
|
|
INNL / Innocoll Holdings plc
|
|
|
|
|
|
|
|
RLYP / Relypsa, Inc.
|
|
|
|
|
|
|
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SPDR SERIES TRUST - S&P BIOTECH
/ Put Put (78464A950) |
|
|
|
|
|
|
|
032420101 / Anacor Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
PATI / Patriot Transportation Holding, Inc.
|
|
|
|
|
|
|
|
ONSIW / Oncobiologics, Inc. Series A Warrant Expiring 2/18/2018
|
|
|
|
|
|
|
|
VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
VCEL / Vericel Corporation
|
|
|
|
|
|
|
|
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CRVS / Corvus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
LJPC / La Jolla Pharmaceutical Co.
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
NDRM / NeuroDerm Ltd.
|
|
|
|
|
|
|
|
PTX / Pernix Therapeutics Holdings, Inc.
|
|
|
|
|
|
|
|
DERM / Journey Medical Corporation
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
CASC / Cascadian Therapeutics, Inc.
|
|
|
|
|
|
|
|
IBRX / ImmunityBio, Inc.
|
|
|
|
|
|
|
|
PGEN / Precigen, Inc. Call
|
|
|
|
|
|
|
|
OTLK / Outlook Therapeutics, Inc.
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
TRIL / Trillium Therapeutics Inc
|
|
|
|
|
|
|
|
ACAD / ACADIA Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
FOLD / Amicus Therapeutics, Inc.
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
SRNE / Sorrento Therapeutics, Inc.
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc. Put
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|